Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Smith & Nephew Snats ( (SNN) ) has provided an update.
On March 16, 2026, Smith & Nephew filed a Form 6-K stating that it had distributed its 2025 Annual Report to shareholders, detailing performance for the year ended December 31, 2025. The report highlights $6.16 billion in group revenue, stronger margins, and substantial free cash flow growth, underscoring a multi‑year operational and financial transformation.
The company’s 2025 results show mid single‑digit underlying revenue growth, a 160-basis-point improvement in both operating and trading profit margins, and a rise in adjusted return on invested capital despite portfolio headwinds. Management positions these outcomes as the successful conclusion of a three‑year turnaround plan and the foundation for its new “RISE” strategy, which targets faster organic growth, higher profitability and enhanced returns for shareholders over the next phase.
The most recent analyst rating on (SNN) stock is a Buy with a $41.00 price target. To see the full list of analyst forecasts on Smith & Nephew Snats stock, see the SNN Stock Forecast page.
Spark’s Take on SNN Stock
According to Spark, TipRanks’ AI Analyst, SNN is a Outperform.
The score is driven primarily by improving financial performance (margin and cash flow rebound) and supportive technicals (price above major moving averages with positive momentum). Valuation is only average at a 22.7 P/E, while the earnings call adds confidence via upbeat 2026 growth/profit guidance but flags meaningful near-term tariff and reimbursement headwinds.
To see Spark’s full report on SNN stock, click here.
More about Smith & Nephew Snats
Smith & Nephew is a leading global medical technology company focused on the repair, regeneration and replacement of soft and hard tissue. It operates three main business units—Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management—serving growth markets valued at more than $50 billion annually across about 100 countries.
Average Trading Volume: 875,024
Technical Sentiment Signal: Buy
Current Market Cap: $14.04B
See more insights into SNN stock on TipRanks’ Stock Analysis page.